A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer
Takashi Yokoi, Takeshi Tamaki, Toshiki Shimizu, Shosaku NomuraFirst Department of Internal Medicine, Kansai Medical University, Moriguchi City, Osaka, JapanBackground: Low-dose metronomic (LDM) chemotherapy is a novel approach that involves frequent administration of a low dose of chemotherapeutic a...
Guardado en:
Autores principales: | Yokoi T, Tamaki T, Shimizu T, Nomura S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/66978b224fa6412a821f19f149590fb4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing
por: Doi Y, et al.
Publicado: (2016) -
Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy
por: Sugiura Y, et al.
Publicado: (2013) -
Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma
por: Kyoichi Kaira, et al.
Publicado: (2021) -
Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy
por: Hua H, et al.
Publicado: (2017) -
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
por: Richard Derman, et al.
Publicado: (2009)